Supplementary Tables 1-5 from Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer

Supplementary Table S1. Imaging mass cytometry antibody panel information. Supplementary Table S2. TRACERx 100 imaging mass cytometry cohort information. Supplementary Table S3. TRACERx 421 cohort information. Supplementary Table S4. Median cell densities per histology, tissue type and TME class. Supplementary Table S5. Multivariable model of disease-free survival including TAN score, relevant clinical features together with PIK3CA mutation status (a) or recent subclonal expansion (b).